ACLS for the Clinical Pharmacist

More documents

Recommendations

Info

Common Principles in New ACLSGuidelines - 20051. Early, effective bystander CPR2. Early defibrillation - Public Access Defibrillation3. Minimal interruptions in chest compressions4. Establishing a specific diagnosis by ECG5. Choose one antiarrhythmic agentOne, and only one antiarrhythmic should be used.6. If IV access is not established, Intraosseouscannulation is the first line alternative andendotracheal is an alternative.
Pharmacist Involvement• Pharmacists should KNOW:How?Why?…to use an agent…we use an agentWhen? …to use an agentWhat?...to watch for
Page 1 and 2: ACLSfor theClinical PharmacistKrist
Page 3: Why Involve Pharmacist?• Improves
Page 7 and 8: Routes of Medications• IV Push (I
Page 9 and 10: Intraosseous Administration• When
Page 11 and 12: HOW?Medication Administration• Do
Page 13 and 14: Use of Algorithms• Meant to treat
Page 15 and 16: ECG Rhythms• Normal sinus rhythmh
Page 17 and 18: ECG Rhythms• Ventricular Tachycar
Page 19 and 20: Cardiac ArrestManagement1. Pulseles
Page 21 and 22: Asystole and Pulseless ElectricalAc
Page 23 and 24: Asystole and PEA AlgorithmPEAInterv
Page 25 and 26: BasicPharmacologyReview
Page 27 and 28: Vasopressor Therapy• Increases SB
Page 29 and 30: Catecholamine Pharmacology• Bind
Page 31 and 32: Epinephrine Side Effects• Nervous
Page 33 and 34: Vasopressin Rationale• Enhance or
Page 35 and 36: A = Atropine• 1mg IVP/IO every 3-
Page 37 and 38: Atropine Side Effects• Anticholin
Page 39 and 40: ECG Rhythms• Ventricular fibrilla
Page 41 and 42: VF/PVT Algorithm: SCREAMGive 1 shoc
Page 43 and 44: VF/PVT Algorithm: SCREAMSShock360J
Page 45 and 46: Amiodarone• 300mg IVP/IO once, th
Page 47 and 48: Lidocaine• 1-1.51.5 mg/kg first d
Page 49 and 50: ArrhythmiaManagement•Bradycardia
Page 51 and 52: ECG Rhythms• Sinus bradycardiahea
Page 53 and 54: Bradycardia Algorithm:Pacing Always
Page 55 and 56:
Transcutaneous PacingApparatus
Page 57 and 58:
Epinephrine• Consider epinephrine
Page 59 and 60:
Dopamine Side Effects• Cardiovasc
Page 61 and 62:
Tachycardia Algorithm (continued)At
Page 63 and 64:
Tachycardia Algorithm• Yes 1-2-3,
Page 65 and 66:
Adenosine• To convert SVT: 6 mg r
Page 67 and 68:
Diltiazem (Cardizem)• Use if aden
Page 69 and 70:
Cases:• Rhythm:• What is this?
Page 71 and 72:
Cases:• Rhythm:• What is this?
Page 73 and 74:
Other Code Situations• Pulmonary
Page 75 and 76:
Take Away Points• Most frequently
Page 77:
Supplemental Reading• Cardiovascu
show all

ACLS for the Clinical Pharmacist

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?